^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    VERU-100

    i
    Other names: VERU-100, VERU 100
    Associations

    News

    Trials
    Company:
    Veru Inc
    Drug class:
    GnRH antagonist
    Related drugs:
    Associations

    News

    Trials
    over2years
    To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer (clinicaltrials.gov)
    P1b/2, N=24, Terminated, Veru Inc. | N=40 --> 24 | Trial completion date: Apr 2023 --> Jan 2023 | Active, not recruiting --> Terminated; Study terminated as end points were not achieved at current dose level.
    Enrollment change • Trial completion date • Trial termination • Metastases
    |
    VERU-100